hrp0098p1-156 | GH and IGFs 2 | ESPE2024

Real-world adherence to growth hormone treatment and catch-up growth in children with growth disorders from the French SCOPE study

Polak Michel , Bouhours-Nouet Natacha , van Dommelen Paula , Berger Sophie , Castello-Bridoux Claire , Untereiner Raphaël , Koledova Ekaterina , Tauber Maithé , Linglart Agnès

Background: The Study and Collection of Observational data for Patients with easypod® Connect (SCOPE) French retrospective study follows children with growth disorders treated with recombinant human growth hormone (r-hGH) therapy via the easypod® connected injection device for up to 5 years.Aim: To show the results from the SCOPE study analysing the adherence to r-hGH therapy in a real-world setting and its effec...